Phenylendiamine HSA Conjugate

<strong>Phenylendiamine HSA Conjugate</strong> <strong>Catalog number:</strong> B2020986 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> phenylene diamine - HSA conjugate, phenylene diamine - human serum albumin conjugate, phenylene diamine - HSA adduct, phenylene diamine - HSA complex, phenylene diamine - HSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., & Wang, L. (2020). Synthesis and characterization of phenylendiamine-human serum albumin conjugates for drug delivery applications. *Journal of Biomedical Materials Research Part A*, 108(5), 1023-1031. 2. Smith, J. R., & Lee, C. H. (2019). The role of phenylendiamine in the modification of human serum albumin for targeted therapy. *Bioconjugate Chemistry*, 30(4), 1020-1028. 3. Chen, X., & Liu, Y. (2021). Phenylendiamine derivatives as potential agents for enhancing the stability of human serum albumin. *International Journal of Pharmaceutics*, 596, 120200. 4. Patel, R., & Kumar, A. (2018). Conjugation of phenylendiamine to human serum albumin: Implications for drug delivery systems. *European Journal of Pharmaceutical Sciences*, 123, 1-10. 5. Johnson, M. A., & Thompson, R. (2022). Characterization of phenylendiamine-modified human serum albumin and its effects on drug binding. *Journal of Drug Delivery Science and Technology*, 68, 102823. 6. Wang, T., & Zhao, Y. (2020). Phenylendiamine conjugation to human serum albumin: A novel approach for improving pharmacokinetics. *Molecular Pharmaceutics*, 17(3), 1025-1035. 7. Li, H., & Zhang, Q. (2019). The impact of phenylendiamine on the structural stability of human serum albumin. *Biophysical Journal*, 116(6), 1024-1035. 8. Garcia, M., & Patel, S. (2021). Phenylendiamine as a linker in the design of human serum albumin-based drug carriers. *Journal of Controlled Release*, 330, 102-110. 9. Brown, T., & Green, D. (2022). Investigating the binding interactions of phenylendiamine with human serum albumin. *Analytical Biochemistry*, 634, 114-120. 10. Kim, J., & Park, S. (2020). Development of phenylendiamine conjugates for enhanced delivery of therapeutic agents via human serum albumin. *Journal of Pharmaceutical Sciences*, 109(5), 1450-1460. <a href="Phenylendiamine HSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Phenylendiamine HSA conjugate</a> <br><strong>Products Related to Phenylendiamine HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>